drugset / Trial / NCT03986424
Local Study of Akatinol Memantine in VaD in Russia
RandomizedParallel-groupOpen-labelTreatment
Summary
The study evaluates the clinical efficacy and safety of Akatinol Memantine 20 mg (single-doses) vs. Akatinol Memantine 10 mg (double-doses) in patients suffering from moderate and moderately severe vascular dementia.
Timeline
- Start
- 2018-01-23
- Primary completion
- 2022-06-01
- Completion
- 2022-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Akatinol Memantine | Unknown | 10 mg | Oral |
| Comparator | Akatinol Memantine | Unknown | 20 mg | Oral |